Literature DB >> 33516958

vNOTES Hysterectomy with Sentinel Lymph Node Mapping for Endometrial Cancer: Description of Technique and Perioperative Outcomes.

Yanzhou Wang1, Li Deng1, Shuai Tang1, Yuya Dou1, Yuanyang Yao1, Yudi Li1, Yuan Deng1, Yong Chen1, Zhiqing Liang2.   

Abstract

STUDY
OBJECTIVE: To explore the technique and clinical value of transvaginal natural orifice transluminal endoscopic surgery (vNOTES) in hysterectomy and sentinel lymph node (SLN) mapping for endometrial cancer by comparing its perioperative outcomes with those of laparoscopic staging.
DESIGN: Retrospective cohort study.
SETTING: Department of gynecology at a tertiary medical center. PATIENTS: All women diagnosed with endometrial cancer who underwent minimally invasive surgery at our center between August 2017 and May 2020.
INTERVENTIONS: Both vNOTES and laparoscopic approaches were used for hysterectomy and SLN mapping. The success of SLN detection as well as perioperative outcomes were subsequently analyzed.
MEASUREMENTS AND MAIN RESULTS: This study included 74 patients; 23 patients underwent vNOTES surgery, whereas 51 underwent standard laparoscopic surgery. The total successful SLN detection was 95.7% in the vNOTES group and 92.2% in the laparoscopy group (p >.05), whereas the bilateral success rates were 87.0% and 90.2%, respectively. No difference in SLN detection was observed between the 2 groups in terms of the side-specific mapping efficacy quotient (91.3% vs 91.2%, p = .47). The number of harvested SLNs, operative time, estimated blood loss, and intraoperative complications in the 2 groups were similar. One (4.3%) postoperative complication occurred in the vNOTES group vs 4 (7.9%) in the laparoscopy group (p = .029), and the median postoperative hospital stay was 3 days vs 4 days (p = .003).
CONCLUSION: This study suggests that the vNOTES procedure is feasible, with a potentially decreased postoperative hospital stay, faster recovery, and better cosmetic results. However, prospective research is needed to validate its broader clinical application.
Copyright © 2021 AAGL. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endometrial cancer; Natural orifices transluminal endoscopic surgery; Perioperative outcomes; Sentinel lymph node

Year:  2021        PMID: 33516958     DOI: 10.1016/j.jmig.2021.01.022

Source DB:  PubMed          Journal:  J Minim Invasive Gynecol        ISSN: 1553-4650            Impact factor:   4.137


  6 in total

1.  Safety and Feasibility of Vaginal Delivery in Full-Term Pregnancy After Transvaginal-Natural Orifice Transluminal Endoscopic Surgery: A Case Series.

Authors:  Shoufeng Zhang; Zhiyong Dong; Junling Liu; Zhenyue Qin; Huihui Wang; Mingyue Bao; Weiwei Wei; Ruxia Shi; Jiming Chen; Bairong Xia
Journal:  Front Surg       Date:  2022-04-28

2.  Sentinel Node Biopsy for Endometrial Cancer by Retroperitoneal Transvaginal Natural Orifice Transluminal Endoscopic Surgery: A Preliminary Study.

Authors:  Daniela Huber; Yannick Hurni
Journal:  Front Surg       Date:  2022-05-09

3.  Transvaginal Natural Orifice Transluminal Endoscopic Surgery for Surgical Staging of Early-Stage Ovarian Cancers: A Report of Two Cases.

Authors:  Yannick Hurni; Fabien Romito; Daniela Huber
Journal:  Front Surg       Date:  2022-03-16

4.  Retroperitoneal Sentinel Lymph Node Biopsy by Vaginally Assisted Natural Orifices Endoscopic Transluminal Endoscopic Surgery in Early Stage Endometrial Cancer: Description of Technique and Surgeon's Perspectives after the First Experience.

Authors:  Marie-Pierre Mathey; Fabien Romito; Daniela E Huber
Journal:  Case Rep Oncol       Date:  2022-03-21

5.  Sentinel Node Biopsy by Transvaginal Natural Orifice Transluminal Endoscopic Surgery in a Patient with Early-Stage Cervical Cancer: A Case Report.

Authors:  Yannick Hurni; Daniela E Huber
Journal:  Case Rep Oncol       Date:  2022-05-20

6.  First in-human trial and prospective case series of an articulated laparoscopic camera system in minimally invasive surgery in gynecology: an IDEAL stage 1 and 2a study.

Authors:  Tong Yow Ng; Siew Fei Ngu; Tat Yan Deyoung Kam; Sai Yan Ng; Ping Lai Benny Lo
Journal:  BMJ Surg Interv Health Technol       Date:  2022-03-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.